Navigation Links
Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals

Medimetriks Adds Centany(R) (mupirocin ointment, 2%) and Two New Brands to Dermatology and Podiatry Product Portfolio

FAIRFIELD, N.J., Oct. 28 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company entered into a licensing agreement with Perrigo Company (Nasdaq: PRGO) for the U.S. marketing rights to Centany(R) Ointment and two prescription keratolytic brands. Patented through 2018, Centany(R) represents an important step in Medimetriks' plan to commercialize patent-protected therapies for the Dermatology and Podiatry markets that offer important patient benefits. Medimetriks plans to launch Centany(R) in early 2009, with the two additional products following shortly thereafter.

Previously marketed by Johnson & Johnson's OrthoNeutrogena professional division, Centany(R) is indicated for the topical treatment of impetigo due to Straphylococcus aureus and Streptococcus pyogenes, and will compete in a topical antibiotic market that exceeds $150 million. Centany(R) received a New Drug Approval in December of 2002 based in part on the unique properties of its vehicle, which offers important benefits over its competitors.

The two prescription keratolytic brands are urea-based therapies indicated for the treatment of severe dry skin. They are offered in delivery systems that are gaining wide acceptance in the Dermatology and Podiatry markets and are both patent pending. These new brands will compete in a skin softening market that approaches one million prescriptions annually.

"We are happy to have a partner that brings such a record of success in the branded pharmaceutical business," stated Sharon Kochan, Executive Vice President of Perrigo. "We believe the licensed products are in good hands given Medimetriks management's proven abilities in building a successful business in the Dermatology and Podiatry markets."

Medimetriks President and CEO, Bradley Glassman, commented, "We are pleased to add these prescription brands to our portfolio. Perrigo is known for developing high quality products and we believe these brands will benefit both our core Dermatology and Podiatry audiences and their patients."

Centany(R) is contraindicated in individuals with a history of sensitivity reactions to any of its components. The following local adverse reactions have been reported in connection with the use of Centany(R): application site reactions and pruritus, each in 1% of patients; contact dermatitis and furunculosis, each in 0.7% of patients; and exfoliative dermatitis and rash, each in 0.3% of patients.

Please see full prescribing information.

About Medimetriks Pharmaceuticals, Inc.

Medimetriks Pharmaceuticals develops, licenses and commercializes prescription skincare products primarily for the Dermatology and Podiatry marketplaces. The Company's mission is to enhance patient quality-of-life by providing innovative therapies that advance patient care.

The Company is located at 363 Route 46 West, Fairfield, NJ 07004-2402. Please visit the Medimetriks website at, call (973) 882-7512 or fax (973) 882-7502.

SOURCE Medimetriks Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
2. Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
3. Perrigo Company Announces Appointment of New Board Member
4. Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference
5. Perrigo Announces Approval for Rx Cetirizine Syrup
6. Perrigo Confirms Filing for Generic Version of VANOS(R)
7. Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech
8. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
9. Perrigo Reports Record Sales and Earnings for Third Quarter Fiscal 2008
10. Perrigo Company Announces Quarterly Dividend
11. Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... The men and women on this ... in the country. They have overseen financial turnarounds, shown commitment to their community ... industry as a whole through their advocacy and professional efforts. , Becker's Hospital ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer ... incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product ... Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not only ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and ... offered by healthcare staffing agency Aureus Medical Group . These fields, ... 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... CA (PRWEB) , ... November 26, 2015 , ... ... a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly ... options. These classically-influenced trailer titles work with any font, giving users limitless opportunities ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... Nov. 25, 2015  Linden Care, LLC, a retail ... outcomes for patients suffering from chronic pain, said today ... Temporary Restraining Order (TRO) enjoining Express Scripts from unilaterally ... --> --> The ... its legal options. --> ...
(Date:11/25/2015)... 25, 2015  Henry Schein, Inc., the world,s largest ... dental, medical and animal health practitioners, will unveil at ... Henry Schein ConnectDental® Pavilion , which brings together for ... solutions designed to help any practice or laboratory enter ... for a schedule of experts appearing at the Pavilion. ...
Breaking Medicine Technology: